Literature DB >> 11241915

Role of the surgeon as a variable in the treatment of rectal cancer.

P Hermanek1, P J Hermanek.   

Abstract

Increasingly, data are being accumulated on the influence of intersurgeon variability on outcome after curative surgical treatment of rectal carcinoma. Thus, today the individual surgeon has to be considered as an independent factor influencing locoregional recurrence, as well as survival rates. In general, higher local control and survival can be expected for specialized colorectal surgeons. There are no clear correlations between surgical volume and outcome. Interinstitutional variability in treatment results reflects intersurgeon variability, but analysis is generally more difficult because of a lack of homogeneity with respect to different confounding factors. There are several factors in surgical technique that are important for long-term outcome. Of greatest apparent importance is the adequacy of mesorectal excision (for carcinomas of the middle and lower third, total mesorectal excision; for carcinomas of the upper third, mesorectal excision down to a mesorectal plane 5 cm distal to the gross tumor margin detected by the surgeon in situ). Furthermore, intraoperative local tumor spillage (tumor perforation during mobilization, incision into the tumor), en bloc resection technique, skill, and the extent of regional lymphadenectomy may influence outcome. For quality assurance, detailed operative reports are required, as well as histopathology examinations concerning indicators of surgical oncologic quality discernable from the resection specimens. In future clinical trials of multimodal treatment of rectal cancer, quality assurance of surgery and pathology is necessary for consideration of the surgeon and surgical technique prognostic factors.

Entities:  

Mesh:

Year:  2000        PMID: 11241915     DOI: 10.1002/ssu.3

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  10 in total

Review 1.  Development of quality indicators for colorectal cancer surgery, using a 3-step modified Delphi approach.

Authors:  Anna R Gagliardi; Marko Simunovic; Bernard Langer; Hartley Stern; Adalsteinn D Brown
Journal:  Can J Surg       Date:  2005-12       Impact factor: 2.089

2.  [Structures and volume standards in colon and rectal surgery].

Authors:  U J Roblick; R Keller; P Hildebrand; R Czymek; H-P Bruch
Journal:  Chirurg       Date:  2007-11       Impact factor: 0.955

3.  Primary vitrectomy for rhegmatogenous retinal detachment: an analysis of 512 cases.

Authors:  Heinrich Heimann; Xiulan Zou; Claudia Jandeck; Ulrich Kellner; Nikolaos E Bechrakis; Klaus-Martin Kreusel; Horst Helbig; Lothar Krause; Andreas Schüler; Norbert Bornfeld; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-26       Impact factor: 3.117

4.  The oncological safety of laparoscopic total mesorectal excision with sphincter preservation for rectal carcinoma.

Authors:  F Bretagnol; B Lelong; C Laurent; V Moutardier; A Rullier; G Monges; J-R Delpero; E Rullier
Journal:  Surg Endosc       Date:  2005-05-12       Impact factor: 4.584

5.  Does total mesorectal excision require a learning curve? Analysis from the database of a single surgeon's experience.

Authors:  Seung Yeop Oh; Young Bae Kim; Ok Joo Paek; Kwang Wook Suh
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

6.  Open sphincter-preserving surgery of extraperitoneal rectal cancer without primary stoma and Fast Track Protocol.

Authors:  G Pappalardo; S Coiro; F De Lucia; A Giannella; F Ruffolo; F M Frattaroli
Journal:  G Chir       Date:  2016 Nov-Dec

7.  Molecular and clinico-pathological markers in rectal cancer: a tissue micro-array study.

Authors:  Annelies Debucquoy; Laurence Goethals; Louis Libbrecht; Christiaan Perneel; Karel Geboes; Nadine Ectors; William H McBride; Karin Haustermans
Journal:  Int J Colorectal Dis       Date:  2008-12-03       Impact factor: 2.571

Review 8.  [Curative vs palliative strategies in locoregional recurrence of gastrointestinal malignancies].

Authors:  J R Siewert; F Lordick; K Ott; B L D M Brücher; R Rosenberg
Journal:  Chirurg       Date:  2006-03       Impact factor: 0.955

9.  The role of COX-2 in rectal cancer treated with preoperative radiotherapy.

Authors:  Hanifa Bouzourene; Pu Yan; Dominique Sandmeier; Abderrahim Zouhair; Maurice Matter; Henri Vuilleumier; Philippe Coucke
Journal:  Virchows Arch       Date:  2008-05       Impact factor: 4.064

10.  Comparative study between transanal tube and loop ileostomy in low anterior resection for mid rectal cancer: a retrospective single center trial.

Authors:  Min-Ki Kim; Dae-Youn Won; Jin-Kwon Lee; Won-Kyung Kang; Jun-Gi Kim; Seong Taek Oh
Journal:  Ann Surg Treat Res       Date:  2015-04-30       Impact factor: 1.859

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.